Article info

Download PDFPDF

Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)

Authors

  1. i svetlana.hamm{at}4sc.com
View Full Text

Citation

Bretz AC, Parnitzke U, Kronthaler K, et al
Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)

Publication history

  • Received July 16, 2019
  • Accepted September 20, 2019
  • First published November 8, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.